Alphabetical list of the eHealth country profiles. How Big is the Counterfeit Drug Industry? Every year the global pharmaceutical drug industry sees a rise in the number of counterfeit drug incidents. The size and scope of this industry is astronomical. In over 50% cases today, medicines purchased over the Internet from illegal sites that conceal their physical address have been found to be counterfeit. SiteJabber is a good place to check to see if an online pharmacy is any good. Share this Post (Click Image to Enlarge) The Future of Traceability Repositories and Inventory Management Systems.
Figure 1. I think there is a significant difference between the traceability repositories we see on the market today and those that I think we are likely to see in the future. Today, traceability repositories are typically implemented by software suppliers as standalone applications or modules that we end users refer to as “an EPCIS”. We call it that because the most defining characteristic of these modules is that they implement GS1′s Electronic Product Code Information Services (EPCIS) standard. Today, traceability repository vendors expect customers to buy their traceability module and integrate it with existing applications.
For a long time now I have felt that this approach was less than optimal and I think we will eventually see a switch occur in the software market toward existing application vendors adding traceability repositories and EPCIS interfaces as new features added to their existing functionality. Let me explain. EPCIS is not an application and it is not a repository. 108_celesio_en.pdf (application/pdf Object) LegitScript - Online Pharmacies You Can Trust. Cross-border healthcare: Directive under discussion again | News | EU Corner | European Healthcare Fraud & Corruption Network. Melior Solutions Limited - TTM300 - Product Verfication Solution. Counterfeiting and Piracy of Pharmaceuticals. LexUriServ.do (application/pdf Object) About us. Counterfeit medicines - Counterfeit medicines. Falsified medicines are fake medicines that pass themselves off as real, authorised medicines. The EU has a strong legal framework for the licensing, manufacturing and distribution of medicines, centred around the Directive on falsified medicines for human use, so that only licensed pharmacies and approved retailers are allowed to offer medicines for sale, including legitimate sale via the internet.
The European Medicines Agency is working closely with its partners on the implementation of these laws. Falsified medicines may: contain ingredients of low quality or in the wrong doses;be deliberately and fraudulently mislabelled with respect to their identity or source;have fake packaging, the wrong ingredients, or low levels of the active ingredients. Falsified medicines do not pass through the usual evaluation of quality, safety and efficacy, which is required for the European Union (EU) authorisation procedure. Because of this, they can be a health threat. Increase in falsified medicines. GMP/GDP compliance - Good manufacturing practice / GDP compliance. Good manufacturing practice (GMP) and good distribution practice (GDP) are related aspects of the quality assurance for medicines in the European Economic Area (EEA). The European Medicines Agency plays an important role in coordinating these activities in collaboration with Member States. Good manufacturing practice Good manufacturing practice (GMP) is “that part of quality assurance which ensures that products are consistently produced and controlled to the quality standards appropriate to their intended use.”
The principles and guidelines for GMP are stated in two Directives: Directive 2003/94/EC for medicines and investigational medicines for human use;Directive 91/412/EEC for medicines for veterinary use. GMP guidelines provide interpretation of these principles and guidelines, supplemented by a series of annexes that modify or augment the detailed guidelines for certain types of product, or provide more specific guidance on a particular topic. Good distribution practice The Agency also: Gdpguidelines1.pdf (application/pdf Object) Pharmaceutical and cosmetic products. Healthcare | Sectors. Bridge.